Cédric Ertlé, managing director at Laboratoires Expanscience Mexico, explains the strategy that the affiliate has implemented to obtain 20 and 45 percent of growth in dermocosmetics and rheumatology respectively and showcases the strong potential ahead in both areas in Mexico.
Could you introduce yourself to our international readers as well as the main activities and operations of Laboratoires Expanscience in Mexico?
"In rheumatology, we identified that there are 11 million Mexicans suffering arthritis and only one million of them are being treated. There is big potential in this market and Laboratoires Expanscience has Piascledine, a high-quality product backed up by clinical studies to treat such disease."
